English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

170 million people worldwide are infected with chronic hepatitis c virus (HCV) [1]. There are an estimated 226700 people infected in Australia and it is the most common indication for liver transplantation in this country [2]. Despite this, overall treatment uptake remains low at &lt;2% of patients infected undergoing treatment per year [3]. Rates of admission to hospital with decompensated liver cirrhosis are expected to increase by 190% by 2030 [4]. Cure of chronic HCV infection requires complex treatment regimens for several months.10.31579/2641-5194/021

Is Being a Prisoner, Indigenous or Having a Psychiatric Illness an Acceptable Limitation to Treatment Access for Chronic Hepatitis C Infection?